demonstrated that piR‐1742 promoted renal cell carcinoma malignancy by regulating USP8 stability.[57] On the other hand, piRNAs have the potential to serve as prognostic biomarker in RCC.[58, 59]. Here, USP8 is linked to renal cell adenocarcinoma.